News
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease For prediction of deleterious TP53 mutations, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback